The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.
about
A water-soluble inclusion complex of pedunculoside with the polymer β-cyclodextrin: a novel anti-inflammation agent with low toxicityTacrolimus for the prevention and treatment of rejection of solid organ transplants.Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.Co-administration of furosemide augments tacrolimus-induced impairment in kidney function in rats.FK506 nephrotoxicity.FK506 in pediatric kidney transplantation--primary and rescue experienceMycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy.Tacrolimus in pediatric renal transplantation.The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapyRenal transplantation at the University of Pittsburgh: the impact of FK506.Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) inductionThe effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation.CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft RejectionA four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study.Perianal fistulae in Crohn's Disease: current and future approaches to treatment.The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation.The safety of calcineurin inhibitors for kidney-transplant patients.Penis Allotransplantation in Beagle Dog.Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity.Paediatric kidney transplantation.A Prospective Randomised Paired Trial of Sirolimus versus Tacrolimus as Primary Immunosuppression following Non-Heart Beating Donor Kidney Transplantation.A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.Tacrolimus (FK506)-Associated Renal Pathology.Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs.Pediatric renal transplantation under tacrolimus-based immunosuppression.A prospective randomized trial of FK506-based immunosuppression after renal transplantationClinical and histopathologic examination of renal allografts treated with tacrolimus (FK506) for at least one year.Functional and structural characteristics of experimental FK 506 nephrotoxicity.Effects of nitric oxide synthesis inhibition on FK506-induced nephrotoxicity in rats.Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients.Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients.Renal Allograft Histology at 10 Years After Transplantation in the Tacrolimus Era: Evidence of Pervasive Chronic Injury.Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
P2860
Q28389978-835DB7F6-C5F4-48B5-B20F-113C99EB86BBQ30278052-4910AA92-ACF9-4021-A82F-66CF1C7ECF6AQ31388582-F6E9CCA1-08CE-44FA-9535-1C577274C2B7Q31476804-56A9A74A-435E-4012-90E5-7D98006F2B67Q33693210-DFDB02AF-C597-423A-A58A-FECF71B6BAB1Q34252083-531CC5E7-546F-4188-897E-75BE61AA8C64Q34322260-FE16D9F9-CBE4-4560-B8AC-95AABF1E16BAQ34330427-DD850CA7-74FB-41B5-801E-296342B7AB3CQ34346715-E6969713-3247-4E2F-B096-1B8055307F44Q34481437-B518588A-5486-47A9-B77F-CFC6440A24A9Q34824999-4F06376B-E864-4F63-AB80-9F1E6C6FF443Q35253580-85DEC731-AFEB-408C-B5D4-335278AEAC64Q36119937-E60CF3EE-6D9F-4C3A-8224-2508891514FBQ36761340-209AB2DB-5EAE-45ED-AE89-9FCC35531C9BQ36901437-E31DB35C-7E37-4F36-9984-362C224D58C9Q36912373-766FF38C-F8E5-4E1D-AB61-4B585970C783Q37616110-8B11FEEE-DC0E-44C4-8FED-E5A27B65D982Q37722911-D969EE7D-0302-4465-B949-AB74ECD2849CQ38578386-E9AC5FA8-3A17-4427-B34F-7A02E191D6C2Q38579338-DFF83297-9D17-4F60-9E7B-19F9A4F61A09Q39808031-AC0BA58E-3FFA-47C5-A7C4-14A928777D5DQ40709714-9A007C87-061D-4E0A-825A-E1F9FC9C19E2Q40862165-9B79B016-A84D-48A3-BF18-DD824314DE2BQ41661712-4B64575F-1893-4CA8-B1BB-80E00A7507F4Q41850534-6ED5DCD4-0DC0-497A-913D-28F0FA7E2334Q41973154-75FF729E-BFB0-45FF-B409-1364568F814DQ42010174-7FAD68C8-807D-4FD2-A0B9-58C60339B6BAQ42275158-98351523-94CB-4D68-8E5F-0B93B36FC83BQ42376516-CA41FA2F-DE55-41E6-B34F-79E42F2AF6ABQ42411557-78EAC0FE-93EB-4004-8B51-E50A8E77F9D3Q42537610-851CE3AD-E718-4C0C-913E-D8B58503413CQ42557751-1CC2F730-E51E-40BF-BC19-1C17EE40418FQ43546407-8B38BA95-CE91-46BD-9CAC-91C6DE442BCFQ48125481-3845809B-1E94-48E6-B30B-E9E93693E2D9Q51161846-89462392-566C-48D1-822F-C6B538E2D559Q53103451-F24430AC-6F2F-4FBE-A07C-3BCF09DE6654Q53482976-550322CC-A5E7-4AEC-91BC-59EDA5FE5CB4Q57151742-5CF4CBEC-1470-425D-9AE0-DD0C67BC9469
P2860
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The histopathological changes ...... comparison with cyclosporine.
@ast
The histopathological changes ...... comparison with cyclosporine.
@en
type
label
The histopathological changes ...... comparison with cyclosporine.
@ast
The histopathological changes ...... comparison with cyclosporine.
@en
prefLabel
The histopathological changes ...... comparison with cyclosporine.
@ast
The histopathological changes ...... comparison with cyclosporine.
@en
P2093
P2860
P1476
The histopathological changes ...... comparison with cyclosporine.
@en
P2093
M L Jordan
P S Randhawa
P2860
P356
10.1097/00000478-199301000-00007
P407
P577
1993-01-01T00:00:00Z